{"id":258220,"date":"2025-12-08T05:55:35","date_gmt":"2025-12-08T10:55:35","guid":{"rendered":"https:\/\/ceoworld.biz\/?p=258220"},"modified":"2025-12-08T05:55:35","modified_gmt":"2025-12-08T10:55:35","slug":"a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data","status":"publish","type":"post","link":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/","title":{"rendered":"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data"},"content":{"rendered":"<p>A quiet revolution is reshaping America\u2019s pharmaceutical manufacturing capabilities\u2014one that blends\u00a0cutting-edge\u00a0science, real-time data integrity, and strategic onshoring to strengthen the nation\u2019s drug supply chain. On a recent episode of\u00a0Around\u00a0The\u00a0Block, the podcast powered by <a href=\"https:\/\/www.youtube.com\/watch?v=0VzHevN1A5M&amp;t=4s\" data-wpel-link=\"external\" target=\"_blank\" rel=\"nofollow\">Circular Protocol<\/a>, leaders from Bright Path Laboratories outlined how the future of U.S. medicines is becoming decentralized, locally controlled, and anchored in verifiable data.<\/p>\n<p>Joining the conversation were\u00a0<a href=\"https:\/\/www.linkedin.com\/in\/tquinones\/\" data-wpel-link=\"external\" target=\"_blank\" rel=\"nofollow\">Tony Quinones<\/a>, Co-Founder and CEO of Bright Path Laboratories;\u00a0<a href=\"https:\/\/www.linkedin.com\/in\/michael-a-gonzalez-ph-d-5398276\/\" data-wpel-link=\"external\" target=\"_blank\" rel=\"nofollow\">Michael A. Gonzales<\/a>, Ph.D., Co-Founder and Chief Scientific Officer; and\u00a0<a href=\"https:\/\/www.linkedin.com\/in\/ajazshussain\/\" data-wpel-link=\"external\" target=\"_blank\" rel=\"nofollow\">Ajaz Hussain, Ph.D.<\/a>,\u00a0Advisor\u00a0and former FDA official. They discussed their role in\u00a0EQUIP-A-Pharma, a U.S. government effort launched in August 2024 to reinvent how pharmaceuticals are made and regulated in the United States.<\/p>\n<p><strong>A National Imperative for Secure, On-Demand Drug Manufacturing\u00a0<\/strong><\/p>\n<p>EQUIP-A-Pharma, short for\u00a0Establishing Qualification Processes for Agile Pharmaceutical Manufacturing, is run by the Defense Advanced Research Projects Agency (DARPA) and funded by the ASPR Center of Industrial Base Management and Supply Chain (IBMSC). Its mission is to introduce a modern production framework capable of:<\/p>\n<ul>\n<li>Manufacturing multiple drug types on a single platform<\/li>\n<li>Deploying flexible, point-of-need production sites nationwide<\/li>\n<li>Integrating real-time quality assurance at every step<\/li>\n<li>Reducing environmental impact and\u00a0eliminating\u00a0legacy externalities<\/li>\n<li>Accelerating regulatory review cycles through fully auditable data streams<\/li>\n<\/ul>\n<p>The initiative fits squarely within the U.S. agenda to reshore critical pharmaceutical capabilities,\u00a0establish\u00a0resilient supply chains, and adopt smarter, more responsive medical manufacturing across both civilian and defense sectors.<\/p>\n<p>Bright Path Laboratories, selected in 2024, is at the center of this transformation thanks to its continuous-flow manufacturing systems and patented\u00a0Spinning-Tube-in-Tube (STT) Reactor&#x2122;, which can produce high-quality pharmaceuticals rapidly, consistently, and economically.<\/p>\n<p><strong>Circular Protocol: The Data Trust Layer Next-Generation Healthcare Infrastructure\u00a0<\/strong><\/p>\n<p>A defining feature of the new pharmaceutical paradigm is the ability to generate a\u00a0secure, immutable record of every step in the manufacturing lifecycle\u2014from raw materials to finished product. This is where\u00a0Circular Protocol, a U.S.-born Layer 1 blockchain designed for compliance, privacy, and verifiable healthcare data integrity, becomes essential.<\/p>\n<p>Circular Protocol offers several breakthroughs critical to EQUIP-A-Pharma:<\/p>\n<ol>\n<li><strong> Certified, Auditable Manufacturing Data<\/strong>: Circular\u2019s infrastructure captures data from sensors, equipment, and quality-control checkpoints and secures it on-chain with cryptographic guarantees. This creates a shared source of truth for manufacturers, hospitals, regulators, and suppliers.<\/li>\n<li><strong> Compliance-Ready Architecture<\/strong>: Unlike general-purpose blockchains, Circular Protocol was engineered to meet U.S.\u00a0federal and state compliance requirements, HIPAA-related privacy needs, and enterprise-grade encryption standards.<\/li>\n<li><strong> AI-Verified Insights and Training Validations<\/strong>: Circular provides built-in AI model certification, ensuring that machine-learning systems used for quality control, predictive analytics, and process optimization can be trusted and independently validated.<\/li>\n<li><strong>Enabling the DeSci Transformation<\/strong>: Founder and CEO Dr. Gianluca De Novi, on several occasions, emphasizes that blockchain and AI together unlock the exponential models needed for a new era of scientific and clinical innovation.\u00a0\u201cThey are the backbone of the next generation of healthcare,\u201d he notes. \u201cCertified data and scalable replication are non-negotiable requirements for a modern pharma system. Circular is built precisely for that.\u201d<\/li>\n<li><strong> Real-Time Regulatory Collaboration<\/strong>: By\u00a0eliminating\u00a0siloed data and audit lag, Circular enables regulators to inspect, verify, and approve manufacturing processes in real time, reducing delays and costs while increasing safety and transparency.<\/li>\n<\/ol>\n<p>In the emerging landscape, Circular Protocol serves as the\u00a0data trust layer\u00a0powering the entire ecosystem. It ensures the authenticity, traceability, and privacy of every data point, from drug synthesis to distribution, supporting the U.S. government\u2019s strategic\u00a0objectives\u00a0in healthcare security and supply-chain resilience.<\/p>\n<p><strong>Industry Leaders See a Turning Point\u00a0<\/strong><\/p>\n<p>Bright Path CEO\u00a0Tony Quinones\u00a0sees the collaboration as a milestone for U.S. healthcare innovation:<br \/>\n\u201cWe\u2019re\u00a0thrilled to be working with the U.S. government and technology pioneers like Circular Protocol. If we want a responsive and resilient drug supply chain, we need manufacturing systems that are flexible, data-driven, and capable of operating where patients need them most.\u201d<\/p>\n<p>This partnership is expected to:<\/p>\n<ul>\n<li>Combat drug shortages more effectively<\/li>\n<li>Allow rapid response to emergency medical needs<\/li>\n<li>Enable more agile, localized production<\/li>\n<li>Lay the foundation for personalized and precision medicine<\/li>\n<li>Build a secure national infrastructure powered by trustworthy data<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>A quiet revolution is reshaping America\u2019s pharmaceutical manufacturing capabilities\u2014one that blends\u00a0cutting-edge\u00a0science, real-time data integrity, and strategic onshoring to strengthen the nation\u2019s drug supply chain. On a recent episode of\u00a0Around\u00a0The\u00a0Block, the podcast powered by Circular Protocol, leaders from Bright Path Laboratories outlined how the future of U.S. medicines is becoming decentralized, locally controlled, and anchored in [&hellip;]<\/p>\n","protected":false},"author":5672,"featured_media":258221,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18009],"tags":[36174,36181,36236,36237,36274,36280,36295,36413,37232,37239,37253],"class_list":["post-258220","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-boardroom-advisory","tag-deputy-general-manager-insider","tag-director-insider","tag-chief-visionary-officer-insider","tag-chief-web-officer-insider","tag-director-of-human-empowerment-insider","tag-de-facto-director-insider","tag-corporate-executives-insider","tag-economics-insider","tag-chief-virtual-reality-officer-insider","tag-co-founders-insider","tag-corporate-directors-insider"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v26.7) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data - CEOWORLD magazine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data - CEOWORLD magazine\" \/>\n<meta property=\"og:description\" content=\"A quiet revolution is reshaping America\u2019s pharmaceutical manufacturing capabilities\u2014one that blends\u00a0cutting-edge\u00a0science, real-time data integrity, and strategic onshoring to strengthen the nation\u2019s drug supply chain. On a recent episode of\u00a0Around\u00a0The\u00a0Block, the podcast powered by Circular Protocol, leaders from Bright Path Laboratories outlined how the future of U.S. medicines is becoming decentralized, locally controlled, and anchored in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/\" \/>\n<meta property=\"og:site_name\" content=\"CEOWORLD magazine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ceoworldmag\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-08T10:55:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Francesco Pagano\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ceoworld\" \/>\n<meta name=\"twitter:site\" content=\"@ceoworld\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Francesco Pagano\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/\"},\"author\":{\"name\":\"Francesco Pagano\",\"@id\":\"https:\/\/ceoworld.biz\/#\/schema\/person\/c1935ac3bfbf732a56429ca7dd488f6c\"},\"headline\":\"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data\",\"datePublished\":\"2025-12-08T10:55:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/\"},\"wordCount\":701,\"publisher\":{\"@id\":\"https:\/\/ceoworld.biz\/#organization\"},\"image\":{\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr\",\"keywords\":[\"Deputy General Manager Insider\",\"Director Insider\",\"Chief Visionary Officer Insider\",\"Chief Web Officer Insider\",\"Director of Human Empowerment Insider\",\"De Facto Director Insider\",\"Corporate Executives Insider\",\"Economics Insider\",\"Chief Virtual Reality Officer Insider\",\"Co-Founders Insider\",\"Corporate Directors Insider\"],\"articleSection\":[\"Boardroom Advisory\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/ceoworld.biz\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/\",\"url\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/\",\"name\":\"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data - CEOWORLD magazine\",\"isPartOf\":{\"@id\":\"https:\/\/ceoworld.biz\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr\",\"datePublished\":\"2025-12-08T10:55:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#primaryimage\",\"url\":\"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr\",\"contentUrl\":\"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr\",\"width\":1024,\"height\":1024,\"caption\":\"Tony Quinones\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ceoworld.biz\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boardroom Advisory\",\"item\":\"https:\/\/ceoworld.biz\/boardroom-advisory\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ceoworld.biz\/#website\",\"url\":\"https:\/\/ceoworld.biz\/\",\"name\":\"CEOWORLD magazine\",\"description\":\"The premier global business magazine providing expert insights, analysis, and news for CEOs, executives, industry leaders, and affluent individuals.\",\"publisher\":{\"@id\":\"https:\/\/ceoworld.biz\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ceoworld.biz\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ceoworld.biz\/#organization\",\"name\":\"CEOWORLD magazine\",\"url\":\"https:\/\/ceoworld.biz\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceoworld.biz\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/08\/CEOWORLD-magazine.png\",\"contentUrl\":\"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/08\/CEOWORLD-magazine.png\",\"width\":1024,\"height\":1024,\"caption\":\"CEOWORLD magazine\"},\"image\":{\"@id\":\"https:\/\/ceoworld.biz\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ceoworldmag\",\"https:\/\/x.com\/ceoworld\"],\"description\":\"CEOWORLD Magazine is a leading global business publication providing expert insights, analysis, and rankings for executives and professionals in leadership, finance, strategy, and innovation across industries worldwide.\",\"email\":\"info@ceoworld.biz\",\"telephone\":\"+1 (646) 466-6530\",\"legalName\":\"CEOWORLD Magazine\",\"foundingDate\":\"2008-07-09\",\"duns\":\"221329499\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"51\",\"maxValue\":\"200\"},\"publishingPrinciples\":\"https:\/\/ceoworld.biz\/publishing-principles\/\",\"actionableFeedbackPolicy\":\"https:\/\/ceoworld.biz\/actionable-feedback-policy\/\",\"correctionsPolicy\":\"https:\/\/ceoworld.biz\/corrections-policy\/\",\"ethicsPolicy\":\"https:\/\/ceoworld.biz\/ethics-and-compliance\/\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ceoworld.biz\/#\/schema\/person\/c1935ac3bfbf732a56429ca7dd488f6c\",\"name\":\"Francesco Pagano\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceoworld.biz\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ceoworld.biz\/wp-content\/uploads\/2024\/02\/francesco-pagano-150x150.jpg?wsr\",\"contentUrl\":\"https:\/\/ceoworld.biz\/wp-content\/uploads\/2024\/02\/francesco-pagano-150x150.jpg?wsr\",\"caption\":\"Francesco Pagano\"},\"description\":\"Francesco Pagano, Senior Partner at Jakala, Shareholder and Contributor at Il Sole 24 Ore, MIA at Columbia University School of International and Public Affairs (SIPA), 20+ years of Sales &amp; Marketing in corporate and start-up world. Francesco Pagano is an Executive Council member at the CEOWORLD magazine. You can follow him on LinkedIn.\",\"url\":\"https:\/\/ceoworld.biz\/author\/francesco-pagano\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data - CEOWORLD magazine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/","og_locale":"en_US","og_type":"article","og_title":"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data - CEOWORLD magazine","og_description":"A quiet revolution is reshaping America\u2019s pharmaceutical manufacturing capabilities\u2014one that blends\u00a0cutting-edge\u00a0science, real-time data integrity, and strategic onshoring to strengthen the nation\u2019s drug supply chain. On a recent episode of\u00a0Around\u00a0The\u00a0Block, the podcast powered by Circular Protocol, leaders from Bright Path Laboratories outlined how the future of U.S. medicines is becoming decentralized, locally controlled, and anchored in [&hellip;]","og_url":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/","og_site_name":"CEOWORLD magazine","article_publisher":"https:\/\/www.facebook.com\/ceoworldmag","article_published_time":"2025-12-08T10:55:35+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr","type":"image\/jpeg"}],"author":"Francesco Pagano","twitter_card":"summary_large_image","twitter_creator":"@ceoworld","twitter_site":"@ceoworld","twitter_misc":{"Written by":"Francesco Pagano","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#article","isPartOf":{"@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/"},"author":{"name":"Francesco Pagano","@id":"https:\/\/ceoworld.biz\/#\/schema\/person\/c1935ac3bfbf732a56429ca7dd488f6c"},"headline":"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data","datePublished":"2025-12-08T10:55:35+00:00","mainEntityOfPage":{"@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/"},"wordCount":701,"publisher":{"@id":"https:\/\/ceoworld.biz\/#organization"},"image":{"@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#primaryimage"},"thumbnailUrl":"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr","keywords":["Deputy General Manager Insider","Director Insider","Chief Visionary Officer Insider","Chief Web Officer Insider","Director of Human Empowerment Insider","De Facto Director Insider","Corporate Executives Insider","Economics Insider","Chief Virtual Reality Officer Insider","Co-Founders Insider","Corporate Directors Insider"],"articleSection":["Boardroom Advisory"],"inLanguage":"en-US","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/ceoworld.biz\/#organization"}},{"@type":"WebPage","@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/","url":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/","name":"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data - CEOWORLD magazine","isPartOf":{"@id":"https:\/\/ceoworld.biz\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#primaryimage"},"image":{"@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#primaryimage"},"thumbnailUrl":"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr","datePublished":"2025-12-08T10:55:35+00:00","breadcrumb":{"@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#primaryimage","url":"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr","contentUrl":"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/12\/tony-quinones.jpg?wsr","width":1024,"height":1024,"caption":"Tony Quinones"},{"@type":"BreadcrumbList","@id":"https:\/\/ceoworld.biz\/2025\/12\/08\/a-new-era-for-u-s-pharmaceutical-production-onshore-agile-and-powered-by-certified-data\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ceoworld.biz\/"},{"@type":"ListItem","position":2,"name":"Boardroom Advisory","item":"https:\/\/ceoworld.biz\/boardroom-advisory\/"},{"@type":"ListItem","position":3,"name":"A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data"}]},{"@type":"WebSite","@id":"https:\/\/ceoworld.biz\/#website","url":"https:\/\/ceoworld.biz\/","name":"CEOWORLD magazine","description":"The premier global business magazine providing expert insights, analysis, and news for CEOs, executives, industry leaders, and affluent individuals.","publisher":{"@id":"https:\/\/ceoworld.biz\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ceoworld.biz\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ceoworld.biz\/#organization","name":"CEOWORLD magazine","url":"https:\/\/ceoworld.biz\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceoworld.biz\/#\/schema\/logo\/image\/","url":"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/08\/CEOWORLD-magazine.png","contentUrl":"https:\/\/ceoworld.biz\/wp-content\/uploads\/2025\/08\/CEOWORLD-magazine.png","width":1024,"height":1024,"caption":"CEOWORLD magazine"},"image":{"@id":"https:\/\/ceoworld.biz\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ceoworldmag","https:\/\/x.com\/ceoworld"],"description":"CEOWORLD Magazine is a leading global business publication providing expert insights, analysis, and rankings for executives and professionals in leadership, finance, strategy, and innovation across industries worldwide.","email":"info@ceoworld.biz","telephone":"+1 (646) 466-6530","legalName":"CEOWORLD Magazine","foundingDate":"2008-07-09","duns":"221329499","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"51","maxValue":"200"},"publishingPrinciples":"https:\/\/ceoworld.biz\/publishing-principles\/","actionableFeedbackPolicy":"https:\/\/ceoworld.biz\/actionable-feedback-policy\/","correctionsPolicy":"https:\/\/ceoworld.biz\/corrections-policy\/","ethicsPolicy":"https:\/\/ceoworld.biz\/ethics-and-compliance\/"},{"@type":"Person","@id":"https:\/\/ceoworld.biz\/#\/schema\/person\/c1935ac3bfbf732a56429ca7dd488f6c","name":"Francesco Pagano","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceoworld.biz\/#\/schema\/person\/image\/","url":"https:\/\/ceoworld.biz\/wp-content\/uploads\/2024\/02\/francesco-pagano-150x150.jpg?wsr","contentUrl":"https:\/\/ceoworld.biz\/wp-content\/uploads\/2024\/02\/francesco-pagano-150x150.jpg?wsr","caption":"Francesco Pagano"},"description":"Francesco Pagano, Senior Partner at Jakala, Shareholder and Contributor at Il Sole 24 Ore, MIA at Columbia University School of International and Public Affairs (SIPA), 20+ years of Sales &amp; Marketing in corporate and start-up world. Francesco Pagano is an Executive Council member at the CEOWORLD magazine. You can follow him on LinkedIn.","url":"https:\/\/ceoworld.biz\/author\/francesco-pagano\/"}]}},"_links":{"self":[{"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/posts\/258220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/users\/5672"}],"replies":[{"embeddable":true,"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/comments?post=258220"}],"version-history":[{"count":1,"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/posts\/258220\/revisions"}],"predecessor-version":[{"id":258222,"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/posts\/258220\/revisions\/258222"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/media\/258221"}],"wp:attachment":[{"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/media?parent=258220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/categories?post=258220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ceoworld.biz\/wp-json\/wp\/v2\/tags?post=258220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}